Lorazepam 2 and 4 mg alone and in combination with atropine 0.4 mg and hyoscine 0.4 mg were studied as i.v. surgical premedicants in 150 patients. Relief of anxiety, sedation, patient acceptance, lack of recall and side-effects were evaluated. Hyoscine was found to improve the relief of anxiety and sedation associated with lorazepam, but did not significantly increase lack of recall or patient acceptance. The addition of atropine to lorazepam did not significantly alter its effects. A high frequency of agitation and restlessness in patients receiving lorazepam and hyoscine make this combination undesirable for surgical premedication.
In a number of clinical studies lorazepam has been found to be a useful surgical premedicant. A review of the literature reveals no detailed studies involving combinations of lorazepam with anticholinergic drugs. Many anaesthetists include anticholinergic drugs routinely in premedication, for their vagolytic and drying effects. Therefore we have chosen to study lorazepam 2 and 4 mg alone and in combination with atropine 0.4 mg or hyoscine 0.4 mg given i.v. Relief of anxiety, sedation, lack of recall, patient acceptance and side-effects were evaluated.
METHODS
One hundred and fifty healthy patients in the age range 18-65 yr participated in the study (table I) . Patients with a history of sensitivity to the benzodiazepines and patients undergoing cardiac or neurosurgical procedures were excluded. There were no restrictions on the method of anaesthesia. No patient had received any previous sedative or narcotic on the day of the study. Informed consent was obtained from all patients who participated in the study.
Approximately 1 h before surgery, the patients were brought to a preoperative holding room. An i.v. fluid infusion was started, medications were administered and patient interviews were conducted. The drugs were administered i.v. in a Latin-square sequence in a double-blind manner, the nature of the medication not being known to either the observer or the patient. Six regimens were studied: lorazepam 2 and 4 mg alone (40 patients per group) and in combination with atropine 0.4 mg or hyoscine 0.4 mg (20 patients per group). A trained nurse made all the observations. Before premedication, each patient was asked to evaluate his anxiety as none, mild, moderate or severe. Four minutes after administration of the drug, the nurse observer, without informing the patient, scored the patient's sedation as unchanged (0), improved (1 + , 2 + , 3+ or 4+) or worsened (1 -,2 -,3 -or 4 -) as compared with the patient's unpremedicated state. The patient was then asked to score his anxiety in a similar manner as compared with his unpremedicated state. The evaluation of sedation and relief of anxiety was repeated at 8, 16 and 32 min. Throughout the period before operation, observations were made for signs or symptoms of drug side-effects and of sensitivity.
The patient's recall was tested by showing a randomized series of "memory cards" (pictures of familiar scenes or objects) at 1,2,4, 8,16 and 32 min.
For those patients who went to the recovery room, the recovery room nurses noted the time of patient responsiveness to command. The occurrence of nausea and vomiting was noted also.
Interviews were conducted 24 h after surgery, at which time the patient was requested to score the pre-medication subjectively: poor (0), fair (1+), good (2 + ) or excellent (3 + ). The patient was asked if he recognized the "memory cards" shown before surgery from a composite of eight pictures. The patient was asked also if he or she remembered the preoperative room, operating room and recovery room.
Variables such as height, weight, sex, race, type of anaesthesia and type of surgery were analysed. No significant differences were found between any of the study groups. Statistical analysis of the data was completed using the ridit transformation (Bross, 1958; Selvin, 1977) . This is an appropriate method for dealing with ordered categorical data, in that arbitrary classifications acquire a valuable interpretation in terms of probabilities, and skewed data tend to be normalized. The scores for patients who received lorazepam only at the 4-min observation period for patient anxiety and patient sedation were used as the reference set for anxiety and sedation analysis respectively. For patient acceptance, the corresponding scores were used as the reference set. By using the 4-min observations for the anxiety and sedation reference, intergroup effects and effect of time can be demonstrated.
Analysis based on ridit transformation is closely related to analysis using the Wilcoxon rank test. For analysis of the transformed data, analysis of variance was used. An appropriate Chi-square statistic was used to test for a difference between the group means of the various drug combinations and a Fisher least significant difference procedure was used for multiple paired comparison of the means.
For all the variables in the study, a higher ridit score indicated a greater drug effect and vice versa. The mean ridit score for any variable was 0.5 in the total population. Two standard deviations were computed as 2 SD = (table II, fig. 1 ). There was an increase in the mean scores (greater relief of anxiety) over the tested time period for all drugs. Lorazepam 4 mg alone scored significantly higher (P<0.05) than lorazepam 2 mg alone. The addition of atropine to lorazepam did improve anxiety scores, but the changes were not significant. The addition of hyoscine, however, improved significantly (P< 0.05) the anxiety scores associated with both doses of lorazepam. Sedation (table II, fig. 2 ). The sedation results are similar to those seen for relief of anxiety. Lorazepam 4mg was significantly better (P<0.05) than lorazepam 2 mg. The addition of hyoscine to lorazepam improved significantly (P<0.05) the sedation scores. The addition of atropine resulted in higher sedation scores although the differences were not significant.
Relief of anxiety
Patient acceptance (table II, fig. 3 ). There were no significant differences in the acceptance rating of any of the drug combinations. Effect on recall ( fig. 4) . No patient failed to remember the preoperative room or receiving the study medications. As expected, lorazepam 4 mg produced greater lack of recall than lorazepam 2 mg. No significant difference was noted when either atropine or hyoscine was given with lorazepam. There was a positive time-effect relationship with all of the study drugs (a greater lack of recall at later test time intervals).
Side-effects (table III) . Vital signs remained stable before surgery. Nausea and vomiting were rare. Dizziness and blurred vision were more frequent in patients who received hyoscine. Dryness of the mouth was a complaint only of those patients who received atropine or hyoscine, the frequency being greater following hyoscine. Agitation and hallucination were the most troublesome side-effects. These occurred mainly in patients receiving lorazepam plus hyoscine, usually occurring 15-30 min after injection. The frequency of agitation with lorazepam 4 mg and hyoscine was so great (six of 10 patients) that the group was discontinued after 10 patients had been studied.
Recovery room. For patients receiving general anaesthesia, there was no difference in the frequency of nausea or vomiting in any of the study groups. Patients receiving lorazepam plus hyoscine tended to sleep longer (approximately 50-60 min) than those 
DISCUSSION
A number of studies have been published describing lorazepam as an effective surgical premedicant (Conner et al., 1976; Pandit, Heisterkamp and Cohen, 1976; Dundee et al., 1977; Blitt, 1976) . In clinical practice, many anaesthetists include routinely an antichounergic drug, usually either atropine or hyoscine in surgical premedication. This study was designed to investigate possible drug interactions of atropine and hyoscine when combined with lorazepam.
It has been well known that both atropine and hyoscine have central nervous system activity. Ketchum, Slidell and Crowell (1973) studied these anticholinergic agents over a wide dose range and found that both drugs produced similar central nervous system effects. However, hyoscine was eight to nine times more potent than atropine in this respect. A syndrome of delirium, restlessness, confusion and hallucination occurred with hyoscine 24 [xg kg" 1 and atropine 174 fxg kg" 1 given i.m. This central nervous system effect of hyoscine would explain the greater sedative properties of hyoscine as compared with atropine in the doses used clinically. It would also seem logical that hyoscine may produce centrally mediated side-effects of drug interaction such as agitation and confusion.
Conner and others (1977) studied i.v. hyoscine 0.4 mg and atropine 0.4 mg given alone and in combination with morphine 5 and 10 mg. As might be expected, atropine provided no sedation or lack of recall. Hyoscine was found to be a potent sedative, especially when combined with morphine. Lack of recall with hyoscine alone or with morphine was negligible, being only 7% at 1 h after injection.
In this study hyoscine, unlike atropine, did significantly improve the sedative and anxiolytic scores of lorazepam. Neither lack of recall nor patient acceptance were altered significantly by the addition of atropine or hyoscine. Side-effects directly related to hyoscine, however, proved to be a problem. The frequency of agitation before operation following lorazepam 2 mg with hyoscine was 25%. Agitation, confusion or hallucinations occurred in six of the 10 patients who received lorazepam 4 mg with hyoscine. This was unusual with lorazepam alone or in combination with atropine. Patients receiving lorazepamhyoscine combinations also tended to sleep longer in the recovery room after general anaesthesia. 
SUMARIO
Se estudiaron lorazepam 2 y 4 mg solos y en combinacion con atropina 0,4 mg e hioscina 0,4 mg como premedicamentos quiriirgicos intravenosos en 150 pacientes. Se evaliio el alivio de ansiedad, sedaci6n, aceptacion del paciente, falta de memoria y efectos colaterales. Se descubrio que la hioscina aumentaba el alivio de ansiedad y la sedation asociada con el lorazepam, pero no aumento significativamente la perdida de la memoria o aceptacion del paciente. La adicion de atropina al lorazepam no altero significativamente sus efectos. Una alta frecuencia de agitation e inquietud en los pacientes que recibieron lorazepam e hioscina hacen indeseable esta combinacion para premedicacion quirurgica.
